Read + Share
Zhu Q, Chen J, Liu H, Zhao J, et al. The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in
second-line treatment: a systematic review and bayesian network meta-analysis. BMC Cancer 2024;24:706.
PMID: 38851712
|
 |
|
Zhu Q, Chen J, Liu H, Zhao J, et al. The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in
second-line treatment: a systematic review and bayesian network meta-analysis. BMC Cancer 2024;24:706.
PMID: 38851712
|
|
|
|